中文名 | CD437 |
英文名 | CD437 |
别名 | 阿达帕琳杂质E O-去甲阿达帕林 邻去甲基阿达帕林 6-[3-(1-金刚烷基)-4-羟基苯基]-2-萘甲酸 6- [3-(1-金刚烷基)-4-羟基苯基]萘-2-羧酸 |
英文别名 | CD437 ADAP-IMH ADAP-IME Adapalene IMpurity F O-DesMethyl Adapalene AHPN, 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid 6-(4-hydroxy-3-tricyclo(3.3.1.1(3,7))dec-1-ylphenyl)-2-naphthalenecarboxylic 2-naphthalenecarboxylicacid,6-(4-hydroxy-3-tricyclo(3.3.1.1(3,7))dec-1-ylphen |
CAS | 125316-60-1 |
EINECS | 200-258-5 |
化学式 | C27H26O3 |
分子量 | 398.49 |
密度 | 1.290 |
熔点 | 271.6-276°C |
沸点 | 595.0±50.0 °C(Predicted) |
溶解度 | DMSO: 26 mg/mL |
酸度系数 | 4.17±0.30(Predicted) |
存储条件 | -20°C |
外观 | 固体 |
颜色 | yellow |
体外研究 | CD437 is a selective RARγ agonist. Growth inhibition by CD437 in these lung cancer cell lines is apparent after 2 days of treatment with 10 μM CD437. Dose-response experiments demonstrate that CD437 reduces the numbers of H460, SK-MES-1, A549, and H292 cells with 50% inhibitory values of approximately 0.5, 0.4, 3, and 0.85 μM, respectively. Treatment for 72 h with CD437 causes a strong dose-dependent growth inhibition in all melanoma cell lines. At a concentration of 5 μM CD437, only about 5 to 25% of the cells remain viable after 3 d. The concentrations of CD437 required for 50% growth inhibition (IC50) range from 10 μM for MeWo to 0.1 μM for SK-Mel-23 showing the highest sensitivity. |
体内研究 | Tumors in CD437-treated mice stop growing, an effect that becomes already statistically significant (P<0.01) at day 13, 3 d after first administration of CD437, and is maintained for more than 3 wk after discontinuation of treatment. Further histologic analysis demonstrates marked c-fos mRNA levels at the tumor-stroma edge in CD437-treated tumors. |
安全术语 | S22 - 切勿吸入粉尘。 S24/25 - 避免与皮肤和眼睛接触。 |
WGK Germany | 3 |
RTECS | QJ1975900 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.509 ml | 12.547 ml | 25.095 ml |
5 mM | 0.502 ml | 2.509 ml | 5.019 ml |
10 mM | 0.251 ml | 1.255 ml | 2.509 ml |
5 mM | 0.05 ml | 0.251 ml | 0.502 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!